Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
Resource Type
Article
Authors
André, Fabrice ; O'Regan, Ruth ; Ozguroglu, Mustafa ; Toi, Masakazu ; Xu, Binghe ; Jerusalem, Guy ; Masuda, Norikazu ; Wilks, Sharon ; Arena, Francis ; Isaacs, Claudine ; Yap, Yoon-Sim ; Papai, Zsuzsanna ; Lang, Istvan ; Armstrong, Anne ; Lerzo, Guillermo ; White, Michelle ; Shen, Kunwei ; Litton, Jennifer ; Chen, David ; Zhang, Yufen ; Ali, Shyanne ; Taran, Tetiana ; Gianni, Luca
Source
In The Lancet Oncology May 2014 15(6):580-591
Subject
Primary Research Articles
Language
ISSN
1470-2045